Insider Sale by Smither John W (Dir)
Trade Summary
6 days ago, Smither John W, serving as Dir at NewAmsterdam Pharma Co N.V. (NAMS), sold 1,600 shares at $25.32 per share, for a total transaction value of $40,512.00. Following this transaction, Smither John W now holds 8,760 shares of NAMS.
This sale represents a 15.44% decrease in Smither John W's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Friday, September 4, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 9, 2026 at 4:30 PM ET, 5 days after the trade was made.
NewAmsterdam Pharma Co N.V. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$25.32
Quantity
1,600
Total Value
$40,512.00
Shares Owned
8,760
Trade Date
6 days ago
SEC Filing Date
at 4:30 PM ET
Filed 5 days after trade
Discussion